BetaGlue Technologies
BetaGlue Technologies

betaglue.com

BetaGlue Technologies is a clinical stage Italian start-up that has developed a highly innovative and proprietary β-emitting bio-compatible compound, locally delivered via a dedicated minimally-invasive delivery system, targeting solid tumors and surgical resection margins.
This solution guarantees a precise delivery of the required dose of radiation energy where it is needed, overcoming some disadvantages of external beam radiation therapy where healthy tissue is irradiated and cancerous tissue is difficult to reach. Initial target indications are prevention of lung biopsy complications, treatment of unresectable tumors such as Liver and Lung, as well as margin treatment for Breast Cancer.


Antonino Amato

Antonino Amato
CEO

Panakès board member
Diana Saraceni

Diana Saraceni